The development of a meaningful strategy for the implementation of rapid microbiological methods requires a certain level of knowledge, skills and competencies on the subject, including the scientific, regulatory and business expectations when assessing and validating RMM technologies. We can provide in-house, world-class professional training and consulting by a world-class technology leader and subject matter expert on RMMs. An overview of our training and consulting services is provided below. Please click here to contact us to discuss our fees and scheduling opportunities.
Dr. Miller is an internationally recognized expert in the due diligence, validation, registration and implementation of rapid microbiological methods. He is the editor of PDA's Encyclopedia of Rapid Microbiological Methods, is co-chairing the revision of PDA Technical Report No. 33: Evaluation, Validation and Implementation of New Microbiological Testing Methods, and is a renowned speaker at numerous RMM conferences around the world. Dr. Miller's extensive Curriculum Vitae (CV) includes a listing of RMM publications and presentations. Click here to view and download Dr. Miller's Curriculum Vitae (CV).
Companies find that in-house training is the most cost-effective means to improve the skills and capabilities of their employees.
Dr. Miller can deliver a comprehensive and interactive two-day, one-day or half-day training course that will be tailored to your company's needs.
An example two-day syllabus is provided below:
Are you considering implementing rapid micro methods but don't have the in-house expertise to champion these efforts? Are you designing a new RMM technology and want to develop a robust strategy for commercialization? Concerned about regulatory impact and return on investment? Our RMM expert can provide guidance and support in all of these areas, whether you are a supplier of new microbiology technologies or an end-user.
Dr. Miller teams with RMM customers to coordinate the initial assessment of rapid micro methods, recommends the best technology, and creates feasibility and validation test plans, comparability protocols and Quality Expert Reports. He has developed extensive return on investment (ROI) models for rapid micro methods and will work with your senior management and finance groups to gain approval for RMM implementation. Dr. Miller provides an in-depth understanding of FDA and EMEA regulatory expectations for RMM validation and implementation, and can act as your liaison when meeting with regulatory agencies and competent authorities.
Working directly with RMM innovators, start-up companies and global RMM suppliers, Dr. Miller provides technical, regulatory, marketing, sales, business and strategic direction during the design and commercialization of next generation microbiology technologies.
Venture Capital firms interested in early-stage, high-potential companies often look toward experts with technology backgrounds, business training and deep industry experience to help guide them in understanding the long-term potential for their investments. Dr. Miller has experience in assisting a number of VC firms in providing commercialization, strategic and technical direction when considering investing in rapid microbiology opportunities.